Global Testicular Cancer Drugs Market 2019-2023
Published: Jan 2019 | Pages: 129 | SKU: IRTNTR30683 |
Below are some of the key findings from this testicular cancer drugs market analysis report
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Global testicular cancer drugs industry overview
The availability of combination therapies for the treatment of testicular cancer is one of the critical reasons that will drive the testicular cancer drugs market’s growth. Combination therapy is preferred over single-drug therapy as its use has increased the survival rate to 95% in patients with testicular cancer. This therapy consists of two treatment regimens, namely etoposide, ifosfamide, and cisplatin combination therapy and bleomycin, etoposide, and cisplatin therapy. This has encouraged researchers from various institutes such as the Institute of Cancer Research to discover new combination therapies that can treat drug-resistant testicular germ cell cancer.
The development of novel treatment therapies by researchers has also encouraged the production of combinations of existing approved testicular cancer drugs. This will drive the testicular cancer drugs market to grow at a CAGR of over 4% during the forecast period. Researchers are studying chemotherapy drugs such as cabazitaxel and gemcitabine to treat testicular cancer. They are also studying an antibody-drug conjugate, brentuximab vedotin, that combines an anti-CD30 antibody with the drug monomethyl auristatin E.
Top testicular cancer drugs companies covered in this market research report
The testicular cancer drugs market is fairly concentrated. Market vendors are focusing on developing advanced diagnostic methods for testicular cancer. By offering a complete analysis of the market’s competitive landscape and information on the products offered by the companies, this testicular cancer drugs industry analysis report will allow the clients to identify new growth opportunities and design innovative strategies to improve their share in the market.
The report offers a complete analysis of various companies including:
- Baxter
- Bristol-Myers Squibb
- Eli Lilly
- Pfizer
- Teva Pharmaceutical
Testicular cancer drugs market segmentation based on geographic regions
- Asia
- Europe
- North America
- ROW
North America will contribute to the highest growth of the global testicular cancer drugs market throughout the forecast period. The growing awareness of testicular cancer through initiatives implemented by various organizations such as the Testicular Cancer Society and Testicular Cancer Foundation is one of the major reasons for high growth of the testicular cancer drugs market in this region.
Testicular cancer drugs market segmentation based on the type
- Non-seminoma
- Seminoma
Non-seminoma is a commonly occurring type of testicular cancer and the availability of effective drugs to treat patients with non-seminoma is also high. As a result, the non-seminoma segment will account for the highest market share in the testicular cancer drugs market.
Key highlights of the global testicular cancer drugs market for the forecast years 2019-2023:
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the testicular cancer drugs market during the next five years
- Precise estimation of the global testicular cancer drugs market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the testicular cancer drugs industry across various geographies such as Asia, Europe, North America, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details on factors that will challenge the growth of multivariable transmitters companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: PIPELINE ANALYSIS
- Pipeline analysis
PART 05: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY TYPE
- Market segmentation by type
- Comparison by type
- Non-seminoma - Market size and forecast 2018-2023
- Seminoma - Market size and forecast 2018-2023
- Market opportunity by type
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
- Market trends
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Baxter
- Bristol-Myers Squibb
- Eli Lilly
- Pfizer
- Teva Pharmaceutical
PART 14: APPENDIX
- Research methodology
- List of abbreviations
PART 15: EXPLORE TECHNAVIO
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis